| Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening N Segnan, C Senore, B Andreoni, A Azzoni, L Bisanti, A Cardelli, ... Gastroenterology 132 (7), 2304-2312, 2007 | 315 | 2007 |
| The impact of immunochemical faecal occult blood testing on colorectal cancer incidence L Ventura, P Mantellini, G Grazzini, G Castiglione, C Buzzoni, T Rubeca, ... Digestive and Liver Disease 46 (1), 82-86, 2014 | 144 | 2014 |
| Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? G Grazzini, CB Visioli, M Zorzi, S Ciatto, F Banovich, AG Bonanomi, ... British journal of cancer 100 (2), 259-265, 2009 | 136 | 2009 |
| Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the … G Grazzini, L Ventura, M Zappa, S Ciatto, M Confortini, S Rapi, T Rubeca, ... Gut 59 (11), 1511-1515, 2010 | 134 | 2010 |
| Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme S Ciatto, F Martinelli, G Castiglione, P Mantellini, T Rubeca, G Grazzini, ... British journal of cancer 96 (2), 218-221, 2007 | 112 | 2007 |
| Measuring interval cancers in population‐based screening using different assays of fecal occult blood testing: the District of Florence experience M Zappa, G Castiglione, E Paci, G Grazzini, T Rubeca, P Turco, E Crocetti, ... International journal of cancer 92 (1), 151-154, 2001 | 111 | 2001 |
| Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results G Grazzini, G Castiglione, C Ciabattoni, F Franceschini, D Giorgi, S Gozzi, ... European Journal of Cancer Prevention 13 (1), 19-26, 2004 | 99 | 2004 |
| Faecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screening CG Fraser, T Rubeca, S Rapi, LS Chen, HH Chen Clinical Chemistry and Laboratory Medicine (CCLM) 52 (8), 1211-1216, 2014 | 89 | 2014 |
| Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood G Castiglione, G Grazzini, G Miccinesi, T Rubeca, C Sani, P Turco, ... Journal of medical screening 9 (3), 99-103, 2002 | 80 | 2002 |
| Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests G Castiglione, M Zappa, G Grazzini, T Rubeca, P Turco, C Sani, S Ciatto Journal of Medical Screening 7 (1), 35-37, 2000 | 67 | 2000 |
| Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme G Castiglione, CB Visioli, S Ciatto, G Grazzini, AG Bonanomi, T Rubeca, ... British Journal of Cancer 96 (11), 1750-1754, 2007 | 41 | 2007 |
| Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy PG Rossi, G Grazzini, M Anti, D Baiocchi, A Barca, P Bellardini, S Brezzi, ... Journal of medical screening 18 (3), 121-127, 2011 | 40 | 2011 |
| Evaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB Gold and OC Sensor assays in a consecutive prospective screening series T Rubeca, S Rapi, M Confortini, M Brogioni, G Grazzini, M Zappa, D Puliti, ... The International journal of biological markers 21 (3), 157-161, 2006 | 40 | 2006 |
| A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based … B Passamonti, M Malaspina, CG Fraser, B Tintori, A Carlani, V D'Angelo, ... Gut 67 (3), 485-496, 2018 | 37 | 2018 |
| Colorectal cancer screening by fecal occult blood testing: results of a population-based experience G Grazzini, G Castiglione, A Isu, P Mantellini, T Rubeca, C Sani, P Turco, ... Tumori Journal 86 (5), 384-388, 2000 | 37 | 2000 |
| Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the … C Senore, M Zappa, C Campari, S Crotta, P Armaroli, A Arrigoni, ... Gut 69 (3), 523-530, 2020 | 36 | 2020 |
| Gastric cancer after positive screening faecal occult blood testing and negative assessment M Zappa, CB Visioli, S Ciatto, G Grazzini, T Rubeca, AG Bonanomi, ... Digestive and liver disease 39 (4), 321-326, 2007 | 35 | 2007 |
| Analysis of morphologic patterns of fine‐needle aspiration of the breast to reduce false‐negative results in breast cytology P Bulgaresi, MP Cariaggi, L Bonardi, MF Carozzi, M Confortini, L Galanti, ... Cancer Cytopathology 105 (3), 152-157, 2005 | 23 | 2005 |
| A feasibility study of the use of the AutoPap screening system as a primary screening and location‐guided rescreening device M Confortini, L Bonardi, P Bulgaresi, MP Cariaggi, S Cecchini, S Ciatto, ... Cancer Cytopathology: Interdisciplinary International Journal of the …, 2003 | 23 | 2003 |
| How to improve the performances of Fecal Immunological Tests (FIT): Need for standardization of the sampling and pre-analytical phases and revision of the procedures for … S Rapi, T Rubeca, CG Fraser The International Journal of Biological Markers 30 (1), 127-131, 2015 | 20 | 2015 |
